OXM vs GH

For growth investors, Guardant Health, Inc.

(GH) is the stronger pick with 32. 9% revenue growth year-over-year, versus -3. 5% for Oxford Industries, Inc. (OXM). Oxford Industries, Inc. (OXM) offers the better valuation at 7. 7x trailing P/E (20. 3x forward), making it the more compelling value choice. Analysts rate Oxford Industries, Inc. (OXM) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Guardant Health, Inc.

(GH) delivered a total return of -31. 9%, compared to -39. 3% for Oxford Industries, Inc. (OXM). Over 10 years, the gap is even starker: GH returned +186. 5% versus OXM's +2. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Guardant Health, Inc.

(GH) is the lower-risk stock at 0. 86β versus Oxford Industries, Inc. 's 1. 68β — meaning OXM is approximately 95% more volatile than GH relative to the S&P 500.

By revenue growth (latest reported year), Guardant Health, Inc.

(GH) is pulling ahead at 32. 9% versus -3. 5% for Oxford Industries, Inc. (OXM). On earnings-per-share growth, the picture is similar: Oxford Industries, Inc. grew EPS 53. 7% year-over-year, compared to 6. 7% for Guardant Health, Inc.. Over a 3-year CAGR, GH leads at 29. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Oxford Industries, Inc.

(OXM) is the more profitable company, earning 6. 1% net margin versus -42. 4% for Guardant Health, Inc. — meaning it keeps 6. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OXM leads at 7. 8% versus -44. 4% for GH. At the gross margin level — before operating expenses — GH leads at 64. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for GH: 44.

3% to $133. 14.

In this comparison, OXM (6.

0% yield) pays a dividend. GH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Guardant Health, Inc.

(GH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 86), +186. 5% 10Y return). Oxford Industries, Inc. (OXM) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GH: +186. 5%, OXM: +2. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (OXM (Consumer Cyclical) and GH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OXM is a small-cap deep-value stock; GH is a mid-cap high-growth stock. OXM pays a dividend while GH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.